Buy now (tactical entry): pre-market $183.29 is sitting right on key support (S1 ~$183.41), offering a favorable near-term risk/reward for an impatient buyer.
Options positioning is notably bullish (very low put/call ratios), and hedge funds are accumulating—both supportive for upside follow-through.
Expect choppiness around the Q4 earnings event today; the setup is still attractive because downside to S2 ($181.84) is limited versus upside to R1/R2 ($188.50–$190.07).
Technical Analysis
Trend/Momentum: MACD histogram is negative (-0.365) but negatively contracting → bearish momentum is fading rather than accelerating.
RSI: RSI(6) ~54.7 (neutral) → no overbought condition; room for a push higher if buyers step in.
Moving averages: converging MAs → consolidation/inflection zone (often precedes a larger move).
Key levels:
Support: S1 ~$183.41 (price is ~at/just below it), then S2 ~$181.84.
Resistance: Pivot ~$185.95, then R1 ~$188.50 and R2 ~$190.07.
Pattern-based forward drift (similar candlesticks): modest edge to small next-day weakness (-0.64%), but slightly positive bias over 1 week/month (+0.45% / +0.27%).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment read: bullish (puts are scarce vs calls on both open interest and volume).
Liquidity/interest: total OI ~4,095 with calls dominating (call OI 3,378 vs put OI 717).
Volatility: 30D IV ~23.74 vs historical vol ~33.74 → IV is not extreme; pricing implies the market isn’t panicking.
IV percentile 60.8 (mid-high) with low IV rank (5.11) → elevated vs recent lows, but not stretched vs longer history.
Today’s option volume is light vs 30D avg (33.33%), suggesting positioning is more “held” than aggressively chased today.
Technical Summary
Sell
2
Buy
9
Positive Catalysts
Industry commentary supportive (Truist/BofA): improving macro tide, beverage can growth, disciplined pricing in containerboard; initiatives around intelligent labels seen as positive.
Overall: sales growing slowly, but earnings/margins have softened, making today’s earnings read-through important for a re-acceleration narrative.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent changes show a mildly improving Wall St stance with price targets being raised:
Truist (Buy) PT raised to $234 from $213.
BofA (Buy) PT raised to $198 from $195.
Citi (Neutral) PT raised to $188 from $180.
Pros (bull case): improving macro tailwinds, disciplined pricing, beverage can growth, and constructive commentary on intelligent labels demand catalysts.
Cons (bear case): volumes still described as challenged into 2026 by some analysts; earnings quality needs to improve to justify upside beyond a tactical bounce.
Influential/political trading: No recent congress trading data available; no notable politician activity provided.
Wall Street analysts forecast AVY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVY is 205.38 USD with a low forecast of 188 USD and a high forecast of 234 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast AVY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVY is 205.38 USD with a low forecast of 188 USD and a high forecast of 234 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 192.880
Low
188
Averages
205.38
High
234
Current: 192.880
Low
188
Averages
205.38
High
234
BMO Capital
Outperform
maintain
$215 -> $224
AI Analysis
2026-02-06
New
Reason
BMO Capital
Price Target
$215 -> $224
AI Analysis
2026-02-06
New
maintain
Outperform
Reason
BMO Capital raised the firm's price target on Avery Dennison to $224 from $215 and keeps an Outperform rating on the shares after its Q4 earnings beat. With a heightened focus on execution, positive secular trends, and increased cash flow, the firm sees the company on track to better growth and valuation re-rating, the analyst tells investors in a research note.
Citi
Neutral
maintain
$188 -> $201
2026-02-06
New
Reason
Citi
Price Target
$188 -> $201
2026-02-06
New
maintain
Neutral
Reason
Citi raised the firm's price target on Avery Dennison to $201 from $188 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AVY
